Skip to content
Use caution Drug recall · FDA · Published October 3, 2014

Sagent Recalls Ketorolac Injection Due to Labeling Errors

Sagent Pharmaceuticals is recalling specific lots of Ketorolac Tromethamine Injection because the expiration dates on the labels are incorrect or missing.

🇺🇸 FDA recall #D-0027-2015DrugSagent Pharmaceuticals ›
Take action

Contact the company

Recalling firmSagent Pharmaceuticals Inc1901 N Roselle Rd Ste 700 · Schaumburg, IL 60195-3194
✎ GovInfoNow plain-language explainer

Sagent Pharmaceuticals Inc. has recalled Ketorolac Tromethamine Injection, USP (30 mg per mL) in both 1 mL and 2 mL vials due to labeling errors. The affected products were labeled with either an incorrect expiration date or no expiration date at all. This recall affects lots MP5021, MP5024, and MP5025 distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/45738-sagent-pharmaceuticals-inc-recalls-ketorolac-tromethamine-injection-usp-30-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/45738-sagent-pharmaceuticals-inc-recalls-ketorolac-tromethamine-injection-usp-30-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-0027-2015

Cite this page

“Sagent Recalls Ketorolac Injection Due to Labeling Errors.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45738-sagent-pharmaceuticals-inc-recalls-ketorolac-tromethamine-injection-usp-30-mg. Based on FDA recall #D-0027-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0027-2015%22&limit=1).

The FDA announced on Oct. 3, 2014, that Sagent Pharmaceuticals Inc voluntarily recalled Ketorolac Tromethamine Injection due to labeling errors showing incorrect expiration dates. The firm initiated the Class II recall affecting 69,050 vials distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: Sagent Pharmaceuticals
  • Product: Ketorolac Tromethamine INJECTION, USP, 30 mg per mL
  • 1 mL vial (NDC 25021-701-01)
  • 2 mL vial (NDC 25021-701-02)
  • Lot MP5021, Exp. 04/16
  • Lots MP5024, MP5025, Exp. 05/16

The hazard

The recall stems from labeling the product with an incorrect expiration date, according to the FDA.

Context

GovInfoNow's records show Sagent Pharmaceuticals Inc has had 10 other recalls on record since June 7, 2013. Other recent recalls of similar products include a Busulfan Injection recall (May 4, 2026), a VasoCaine Spray recall (Feb. 18, 2026), and a Levocarnitine Injection recall (April 16, 2026).

How to tell if you have this one

Check your vials for NDC numbers 25021-701-01 (1 mL vial) or 25021-701-02 (2 mL vial). Look specifically for Lot numbers MP5021, MP5024, or MP5025. Verify if the expiration date listed on the label is missing or appears incorrect.

  • Brand
    Sagent Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Verify Lot Numbers

    Check the vial labels for lot numbers MP5021, MP5024, or MP5025 and NDCs 25021-701-01 or 25021-701-02.

  2. Contact Supplier

    If you have these specific lots, contact your supplier or Sagent Pharmaceuticals for instructions on how to return or dispose of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 17 months after the firm started it.

1. Firm started the recall: Oct 3, 201412. FDA classified it Class II: Oct 16, 201423. Published in FDA’s Enforcement Report: Oct 22, 201434. FDA terminated the recall: Feb 23, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0027-2015 (October 3, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0027-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA